PMID: 8583245Oct 1, 1995Paper

Conductive interstitial hyperthermia in the treatment of intracranial metastatic disease

Journal of Neuro-oncology
C J MoranN E Fearnot

Abstract

Intracranial metastases commonly complicate oncologic care affecting 140,000 patients per year in the United States. Treatment of these tumors is difficult and often unsuccessful. Hyperthermia is a treatment alternative that has shown promise in treating cancer in other areas. Therefore it was employed in an attempt to provide increased tumor control in CNS metastases. This Phase I and Phase II clinical trial of interstitial hyperthermia with recurrent or progressive intracranial metastatic disease was undertaken to evaluate complications, delivery of heat and patient outcome. Feared complications of clinically significant bleeding, increased mass, or infection from the interstitial implant and treatment did not occur. The seizures which occurred in 4 patients were controlled with additional anticonvulsants. Three venous thromboembolic events were treated medically and with percutaneously placed inferior vena cava filters. The KPS of the majority of patients declined slightly with treatment but rebounded to near baseline within several months. CT scans demonstrated decrease or stabilization of tumor volumes in 7 of the 13 patients. In 4 of these patients, regression or stabilization persisted until death from nonCNS disease. In...Continue Reading

References

Nov 1, 1978·Archives of Neurology·W R MarkesberyA B Young
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·P K SneedD K Ahn
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·M A MackeyJ L Roti Roti
Sep 1, 1991·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·J R FikeP R Stauffer
May 1, 1991·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·J A DeFordC J Moran
Jan 1, 1991·Neuroradiology·J Greenwood
Jul 1, 1990·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·J A DeFordC J Moran
Apr 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S LoefflerE Alexander
Jun 1, 1990·Journal of Neurosurgery·J A MarchoskyC F Babbs
Dec 1, 1990·International Journal of Radiation Oncology, Biology, Physics·D X QinY H Hu
Mar 1, 1990·Radiology·J S CooperI A Lerch
Apr 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J S LoefflerE Alexander
Mar 1, 1989·International Journal of Radiation Oncology, Biology, Physics·M Diener-WestD F Nelson
Aug 1, 1988·International Journal of Radiation Oncology, Biology, Physics·M B Hazuka, J J Kinzie
Feb 15, 1989·Cancer·M PradosP Gutin
Mar 1, 1988·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·T L BorokJ Plafker
Oct 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N SundaresanJ E Hughes
Jul 1, 1988·Neurosurgery·R G Selker
Feb 1, 1988·Radiology·A A KatsamourisC A Athanasoulis
Oct 1, 1986·International Journal of Radiation Oncology, Biology, Physics·P K SneedP H Gutin
Mar 1, 1987·Journal of Surgical Oncology·F K StormD L Morton
Jul 1, 1985·Cancer·A W SilbermanD L Morton
Jun 1, 1985·Annals of Neurology·J G CairncrossR F DelMaestro
Jun 1, 1984·Cancer Treatment Reviews·N H Greig
Jun 1, 1984·International Journal of Radiation Oncology, Biology, Physics·S A Sapareto, W C Dewey
Jan 1, 1994·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·P SminiaJ Haveman
Aug 1, 1993·Journal of Neuro-oncology·P H GutinP Sneed
Apr 1, 1994·Mayo Clinic Proceedings·J F QuevedoJ R O'Fallon
Jul 1, 1993·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·T NakajimaJ W Strohbehn
Feb 15, 1993·Cancer·J E NaschitzL M Lev

❮ Previous
Next ❯

Citations

Nov 10, 2001·Annual Review of Biomedical Engineering·R B Roemer
Aug 2, 2005·Neuro-oncology·Michael W Graner, Darell D Bigner
Aug 24, 2011·Annals of Surgical Oncology·Xiang ZhangJinxiang Cheng
Jan 5, 1999·IEEE Transactions on Medical Imaging·J De BreeJ J Battermann
Sep 22, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Dong-Chun WangShuo Wang
Oct 9, 2018·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Yoon Hwan ByunSeung Hoon Lee
Oct 6, 2020·Frontiers in Oncology·Sun-Young LeeCarrie Anne Minnaar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Treatment Options in Neurology
John G StewartJohn B Fiveash
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
J F van der KoijkJ J Battermann
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
P R WachsbergerD B Leeper
© 2021 Meta ULC. All rights reserved